Some possibilities of protection against acetylcholinesterase inhibition by organophosphates in vivo.
D000609:Aminoacridines / Q000627:therapeutic use*; D000818:Animals; D001535:Benactyzine / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005260:Female; D008526:Medulla Oblongata / Q000187:drug effects; D062025:Organophosphate Poisoning; D063086:Organothiophosphates; D009946:Organothiophosphorus Compounds / Q000506:poisoning*; D011149:Pons / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D013619:Tacrine / Q000627:therapeutic use*; D014289:Trimedoxime / Q000627:therapeutic use
D000609:Aminoacridines; D002800:Cholinesterase Inhibitors; D063086:Organothiophosphates; D009946:Organothiophosphorus Compounds; C010400:O-ethyl S-(2-dimethylaminoethyl) methylphosphonothioate; D013619:Tacrine; D014289:Trimedoxime; D001535:Benactyzine